多发性硬化症进展的预测因素:一个元分析
1Department of Neurology, The First People's Hospital of Yibin, Yibin, Sichuan, 644000, China. 13541497064@163.com.
概括
男人,吸烟,经常复发和更高的EDSS分数预测了多发性硬化症 (MS) 的进展. 疾病修饰疗法 (DMT) 与较慢的MS恶化有关,突出显示了监测MS的关键因素.
科学领域:
- 神经学 神经学
- 临床研究 临床研究
- 流行病学 流行病学
背景情况:
- 多发性硬化症 (MS) 是一种慢性神经疾病,进展变化.
- 确定MS进展的预测因素对于患者管理和治疗策略至关重要.
研究的目的:
- 系统地审查和元分析影响多发性硬化症进展的预测因素.
- 确定与多发性硬化症恶化相关的关键临床和人口学变量.
主要方法:
- 在主要数据库 (PubMed,Ovid,科学网,威利图书馆,EMBASE) 进行系统的文献搜索,截至2023年8月.
- 包括14项分析年龄,性别,吸烟,疾病持续时间,复发,EDSS,症状和DMT使用等预测因素的研究.
- 根据扩展残疾状况表 (EDSS) 的变化,将患者分为恶化和非恶化组.
主要成果:
- 男性性别 (OR=1.15),吸烟 (OR=1.92),更高的复发频率 (OR=1.05) 和更高的EDSS分数 (OR=1.54) 是MS进展的显著预测因素.
- 疾病修饰疗法 (DMT) 的使用与MS进展风险降低有关 (OR=0.38).
- 发病时的年龄,疾病持续时间和前兆症状并不能显著预测MS进展.
结论:
- 男性性别,吸烟,复发频率增加和EDSS得分更高是多发性硬化症恶化的重要危险因素.
- 使用疾病修饰疗法 (DMT) 似乎是防止多发性硬化症进展的保护因素.
- 这些确定的因素需要密切关注,以监测和管理MS的进展.
相关概念视频
02:07Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
01:15Parkinson's Disease: Overview
323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323